Forward
Restructure Information
On April 28, 2026, the U.S. District Court for the District of New Jersey sentenced Purdue Pharma L.P. in connection with its 2020 Plea Agreement with the U.S. Department of Justice. Purdue is operating as usual and without interruption until May 1, 2026, when it will permanently cease operations. On that day, substantially all of Purdue’s assets will be transferred to a newly formed company, Knoa Pharma LLC. Medicines distributed though Purdue will then be distributed by Knoa Pharma.
